Accessibility Menu
 
Petlife Pharmaceuticals logo

Petlife Pharmaceuticals

(OTC) PTLF

Current Price$0.00
Market Cap$22,400
Since IPO (2011)-100%
5 Year-98%
1 Year+1%
1 Month+0%

Petlife Pharmaceuticals Financials at a Glance

Market Cap

$22,400

Revenue (TTM)

$0.00

Net Income (TTM)

$3.71M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

44.62 (High)

Price

$0.00

Volume

10,010

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PTLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Petlife Pharmaceuticals

Industry

Pharmaceuticals

Headquarters

Los Angeles, CA 90046, US

PTLF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

16%

Return on Assets

-423%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$22.40K

Shares Outstanding

222.12M

Volume

10.01K

Avg. Volume

403.333

Financials (TTM)

Gross Profit

$0.00

Operating Income

$22.66M

EBITDA

$22.87M

Operating Cash Flow

$318.92K

Capital Expenditure

$0.00

Free Cash Flow

$318.92K

Cash & ST Invst.

$54.25K

Total Debt

$717.18K

Petlife Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2018YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$22.40K

N/A

Market Cap/Employee

$22.40K

N/A

Employees

1

N/A

Net Income

$427.06K

+67.6%

EBITDA

$345.03K

+72.5%

Quarterly Fundamentals

Name
Q2 2018YOY CHG

Net Cash

$793.80K

-97.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$801.65K

+99.6%

Return on Assets

-422.82%

N/A

Return on Invested Capital

16.40%

N/A

Free Cash Flow

$162.45K

-3.6%

Operating Cash Flow

$162.45K

-3.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AOLSAeolus Pharmaceuticals, Inc.
$0.00+0.00%
HCANFHalo Collective Inc.
$0.00+0.00%
FIORFFiore Cannabis Ltd.
$0.00+0.00%
MRRCFWayland Group Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About PTLF

What is the current price of Petlife Pharmaceuticals?

Petlife Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Petlife Pharmaceuticals?

Over the past 52 weeks, Petlife Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Petlife Pharmaceuticals have?

Petlife Pharmaceuticals total debt is unavailable.

How much cash does Petlife Pharmaceuticals have on hand?

Petlife Pharmaceuticals does not have cash on hand data available.

What is Petlife Pharmaceuticals’s dividend yield?

Petlife Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.